P22303 |
ACES_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P22303 |
ACES_HUMAN |
Glaucoma [ICD-11: 9C61] |
P22303 |
ACES_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P22303 |
ACES_HUMAN |
Oesophageal/gastroduodenal disorder [ICD-11: DD90] |
P22303 |
ACES_HUMAN |
Pediculosis [ICD-11: 1G00] |
P22303 |
ACES_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P22303 |
ACES_HUMAN |
Parasitic worm infestation [ICD-11: 1F90] |
P22303 |
ACES_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P22303 |
ACES_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P22303 |
ACES_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P22303 |
ACES_HUMAN |
Substance abuse [ICD-11: 6C40] |
P22303 |
ACES_HUMAN |
Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] |
P22303 |
ACES_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22303 |
ACES_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
P22303 |
ACES_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P40763 |
STAT3_HUMAN |
Psoriasis [ICD-11: EA90] |
P40763 |
STAT3_HUMAN |
Brain cancer [ICD-11: 2A00] |
P40763 |
STAT3_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P40763 |
STAT3_HUMAN |
Liver cancer [ICD-11: 2C12] |
P40763 |
STAT3_HUMAN |
Malignant digestive organ neoplasm [ICD-11: 2C11] |
P40763 |
STAT3_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P40763 |
STAT3_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P40763 |
STAT3_HUMAN |
Respiratory infection [ICD-11: CA07-CA4Z] |
P40763 |
STAT3_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P40763 |
STAT3_HUMAN |
Immune system disease [ICD-11: 4A01-4B41] |
P40763 |
STAT3_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P40763 |
STAT3_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P40763 |
STAT3_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P40763 |
STAT3_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P40763 |
STAT3_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P40763 |
STAT3_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |